Europe
The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities.
Medigene AG announced its participation at the following upcoming investor and scientific conferences
Lonza announced that Standard & Poor’s (S&P) assigned a BBB+ credit rating with stable outlook to Lonza.
Pharma and biotech companies make changes to their board and leadership teams to advance pipelines and strategies, at SQZ, AstraZeneca, Bioasis, and more.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Adocia confirmed its financial calendar for 2019 with a change in date of the annual shareholder’s meeting.
Reflecting the shareholders’ decisions, Michel Baijot is now leading the company as new CEO towards its reassessed strategic goals for 2019 and onwards
The growing edentulous population is expected to be an important factor driving the growth of the global dental biomaterials market throughout the forecast period as people aged 60 years and above are at a high risk of developing dental disorders
Pyrrolobenzodiazepine-based antibody drug conjugate targets AXL, a receptor tyrosine kinase highly expressed in solid tumors
A study published in Clinical Chemistry earlier this month has linked sperm with more DNA damage to repeated miscarriages. Recurring miscarriages, defined as three or more consecutive miscarriages before 20 weeks of pregnancy, occur in 1-2 percent of couples.
PRESS RELEASES